SCHEMBL24659983

SCHEMBL24659983

CC(=O)O[C@@H](C)[C@@H](O)c1cnc(N)c(C#N)n1

nearest known ligand 0.32

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 4/20 0.32
FEN1 P39748 4/20 0.32
ALDH1A1 P00352 3/20 0.32
KMT2A Q03164 1/20 0.32
KDM4E B2RXH2 2/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
RAB9A P51151 1/20 0.32
MAP4K4 O95819 1/20 0.31
MINK1 Q8N4C8 1/20 0.31
TNIK Q9UKE5 1/20 0.31
HPGD P15428 1/20 0.31
MAPK8 P45983 2/20 0.31
PRKD3 O94806 1/20 0.31
PDE9A O76083 1/20 0.31
HSD17B10 Q99714 1/20 0.30
XDH P47989 1/20 0.30
MAPK9 P45984 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24659989 1.00 ALOX5AP (0.32) ALOX5APFEN1ALDH1A1KMT2AKDM4E
SCHEMBL23028982 0.85 ALOX5AP (0.32) ALOX5APFEN1ALDH1A1KMT2AKDM4E
SCHEMBL24659984 0.85 ALOX5AP (0.32) ALOX5APFEN1ALDH1A1KMT2AKDM4E
SCHEMBL23028979 0.85 ALOX5AP (0.32) ALOX5APFEN1ALDH1A1KMT2AKDM4E
SCHEMBL23028974 0.81 HSD17B10 (0.35) ALOX5APFEN1HSD17B10
SCHEMBL23028945 0.81 HSD17B10 (0.35) ALOX5APFEN1HSD17B10
SCHEMBL23028944 0.81 HSD17B10 (0.35) ALOX5APFEN1HSD17B10
SCHEMBL23028963 0.81 HSD17B10 (0.35) ALOX5APFEN1HSD17B10
SCHEMBL23028989 0.81 HSD17B10 (0.35) ALOX5APFEN1HSD17B10
SCHEMBL24574311 0.71 ALOX5AP (0.34) ALOX5APFEN1ALDH1A1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220298178-A1 METHOD FOR PREPARING L-ERYTHROBIOPTERIN COMPOUND SHANGHAI FOREFRONT PHARMA CO., LTD. (CN) 2022-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220298178-A1 METHOD FOR PREPARING L-ERYTHROBIOPTERIN COMPOUND SPR, RNPEP, DHPS ALOX5AP 1021/4885FEN1 500/4885ALDH1A1 1643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.